CompletedPhase 4NCT03052998
Ivermectin Treatment in Patients With Onchocerciasis-associated Epilepsy
Studying Infectious disease with epilepsy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Robert Colebunders
- Principal Investigator
- Michel Mandro, MDChef de Bureau Inspection&Contrôle et Associé de Recherche Clinique
- Intervention
- Ivermectin(drug)
- Enrollment
- 91 enrolled
- Eligibility
- 5 years · All sexes
- Timeline
- 2017 – 2018
Study locations (1)
- Centre de Recherche en Maladies Tropicales de l'Ituri, Rethy, Ituri, Democratic Republic of the Congo
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03052998 on ClinicalTrials.gov